1. Home
  2. NHTC vs SKYE Comparison

NHTC vs SKYE Comparison

Compare NHTC & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Health Trends Corp.

NHTC

Natural Health Trends Corp.

HOLD

Current Price

$1.77

Market Cap

22.1M

Sector

Miscellaneous

ML Signal

HOLD

Logo Skye Bioscience Inc.

SKYE

Skye Bioscience Inc.

HOLD

Current Price

$0.66

Market Cap

24.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NHTC
SKYE
Founded
1988
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.1M
24.7M
IPO Year
1999
2013

Fundamental Metrics

Financial Performance
Metric
NHTC
SKYE
Price
$1.77
$0.66
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$15.00
AVG Volume (30 Days)
33.1K
108.6K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
13.51%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,776,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.55
$0.57
52 Week High
$5.10
$4.99

Technical Indicators

Market Signals
Indicator
NHTC
SKYE
Relative Strength Index (RSI) 39.39 46.19
Support Level $1.55 $0.57
Resistance Level $1.97 $0.84
Average True Range (ATR) 0.10 0.04
MACD 0.03 0.00
Stochastic Oscillator 17.96 63.09

Price Performance

Historical Comparison
NHTC
SKYE

About NHTC Natural Health Trends Corp.

Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and support active, physical, and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and the rest from China, Taiwan, Japan, the United States, and other regions.

About SKYE Skye Bioscience Inc.

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: